Mark Sheptoff Financial Planning LLC Sells 14,346 Shares of UnitedHealth Group Incorporated $UNH

Mark Sheptoff Financial Planning LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 59.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 9,797 shares of the healthcare conglomerate’s stock after selling 14,346 shares during the period. UnitedHealth Group makes up 1.6% of Mark Sheptoff Financial Planning LLC’s investment portfolio, making the stock its 16th largest position. Mark Sheptoff Financial Planning LLC’s holdings in UnitedHealth Group were worth $3,056,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC lifted its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Alps Advisors Inc. grew its position in shares of UnitedHealth Group by 0.8% during the 1st quarter. Alps Advisors Inc. now owns 27,252 shares of the healthcare conglomerate’s stock valued at $14,273,000 after purchasing an additional 220 shares in the last quarter. Bernardo Wealth Planning LLC raised its position in shares of UnitedHealth Group by 4.6% in the first quarter. Bernardo Wealth Planning LLC now owns 833 shares of the healthcare conglomerate’s stock worth $436,000 after buying an additional 37 shares in the last quarter. Finally, Burford Brothers Inc. grew its position in UnitedHealth Group by 3.7% during the first quarter. Burford Brothers Inc. now owns 3,010 shares of the healthcare conglomerate’s stock worth $1,576,000 after buying an additional 107 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $324.29 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business has a 50 day moving average price of $345.84 and a 200-day moving average price of $323.37. The firm has a market cap of $293.75 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same period in the prior year, the business posted $7.15 EPS. The firm’s revenue was up 12.2% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Jefferies Financial Group lifted their price target on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research report on Friday, October 17th. Robert W. Baird reissued an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Morgan Stanley upped their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. KeyCorp upped their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Finally, The Goldman Sachs Group assumed coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 target price for the company. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.